NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Cited by (862)

Items 101–200 of 862

1. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches
   Karol Artur Sadowski, Adrianna Jażdżewska, Jan Kozłowski, Aleksandra Zacny, Tomasz Lorenc, Wioletta Olejarz · 2024 · International Journal of Molecular Sciences
2. Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation
   Eun Ho Kim, Ye Jin Kim, Hyo Sook Song, Youn Kyoung Jeong, Ji Young Lee, Jiwon Sung, Seung‐Hoon Yoo, Myonggeun Yoon · 2016 · Oncotarget
3. High-Frequency Irreversible Electroporation for Intracranial Meningioma: A Feasibility Study in a Spontaneous Canine Tumor Model
   Eduardo L. Latouche, Christopher B. Arena, Jill W. Ivey, Paulo A. Garcia, Theresa E. Pancotto, Noah D. Pavlisko, Scott S. Verbridge, Rafael V. Davalos, John Henry Rossmeisl · 2018 · Technology in Cancer Research & Treatment
4. Tumour-treating fields (TTFields): Investigations on the mechanism of action by electromagnetic exposure of cells in telophase/cytokinesis
   Lukas Berkelmann, Almke Bader, Saba Meshksar, Anne Dierks, Gökce Hatipoglu Majernik, Joachim Kurt Krauss, Kerstin Schwabe, Dirk Manteuffel, Anaclet Ngezahayo · 2019 · Scientific Reports
5. Radiotherapy in Glioblastoma: the Past, the Present and the Future
   Cecelia Gzell, Michael Back, Helen Wheeler, Dale L. Bailey, Matthew C. Foote · 2016 · Clinical Oncology
6. Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot study
   Ignace B. Vergote, Roger von Moos, Luís Manso, Els Van Nieuwenhuysen, Nicole Concin, Cristiana Sessa · 2018 · Gynecologic Oncology
7. NK Cell-Based Glioblastoma Immunotherapy
   Irene Golán, Laura Rodríguez de la Fuente, José A. Costoya · 2018 · Cancers
8. Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells
   Eun Ho Kim, Yunhui Jo, Sei Sai, Mung-Jin Park, Jeong‐Yub Kim, Jin Su Kim, Yeon‐Joo Lee, Jae-Min Cho, Seo‐Young Kwak, Jeong-Hwa Baek et al. · 2019 · Oncogene
9. Stereotactic Laser Interstitial Thermal Therapy for Recurrent High-Grade Gliomas
   Ian Y. Lee, Steven N. Kalkanis, Constantinos G. Hadjipanayis · 2016 · Neurosurgery
10. Permeabilizing Cell Membranes with Electric Fields
    Aguilar, Alondra A., Ho, Michelle C., Chang, Edwin, Carlson, Kristen W., Natarajan, Arutselvan, Marciano, Tal, Bomzon, Ze’ev, Patel, Chirag B. · 2021 · Cancers
11. Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies
    Jacquelyn W. Zimmerman, Hugo Jimenez, Michael J. Pennison, Ivan A Brezovich, Desiree E. Morgan, Albert C. Mudry, Frederico Perego Costa, Alexandre Barbault, Boris Pasche · 2013 · 癌症：英文版
12. Improving Tumor Treating Fields Treatment Efficacy in Patients With Glioblastoma Using Personalized Array Layouts
    Cornelia Wenger, Ricardo Salvador, Peter J. Basser, Pedro Cavaleiro Miranda · 2015 · International Journal of Radiation Oncology*Biology*Physics
13. Contributors to contrast between glioma and brain tissue in chemical exchange saturation transfer sensitive imaging at 3 Tesla
    Rachel Scheidegger, Eric T. Wong, David C. Alsop · 2014 · NeuroImage
14. SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017)
    Maria Martinez‐García, J. Álvarez-Linera, Cristina Carrato, Luis Ley Urzaiz, R. Luque, Xavier Maldonado, Maite Martínez-Aguillo, M Navarro, María Ángeles Vaz Salgado, Miguel Gil‐Gil · 2017 · Clinical & Translational Oncology
15. Tumor-Treating Fields in Glioblastomas: Past, Present, and Future
    Xiaopeng Guo, Xin Yang, Jiaming Wu, Huiyu Yang, Yilin Li, Junlin Li, Qianshu Liu, Wu Chen, Hao Xing, Penghao Liu et al. · 2022 · Cancers
16. Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma
    Justin Low, Michael C. Brown, Zachary J. Reitman, Joshua D. Bernstock, James M. Markert, Gregory K. Friedman, Matthew S. Waitkus, Michelle L. Bowie, David M. Ashley · 2024 · Journal of Clinical Investigation
17. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial
    Santosh Kesari, Zvi Ram, on behalf of EF-14 Trial Investigators · 2017 · CNS Oncology
18. Treating recurrent glioblastoma: an update
    Carlos Kamiya-Matsuoka, Mark R. Gilbert · 2015 · CNS Oncology
19. Nanotherapeutic systems for local treatment of brain tumors
    Rami W. Chakroun, Pengcheng Zhang, Ran Lin, Paula V. Schiapparelli, Alfredo Quiñones‐Hinojosa, Honggang Cui · 2017 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
20. Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study
    Anders Rosendal Korshoej, Frederik Lundgaard Hansen, Axel Thielscher, Gorm von Öettingen, Jens Christian Hedemann Sørensen · 2017 · PLoS ONE
21. The Evolving Role of Tumor Treating Fields in Managing Glioblastoma
    Stuart H. Burri, Vinai Gondi, Paul D. Brown, Minesh P. Mehta · 2017 · American Journal of Clinical Oncology
22. Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
    Zvi Ram on behalf of the EF-14 Trial Investigators, Jay‐Jiguang Zhu, Petya Demireva, Andrew A. Kanner, Susan C. Pannullo, Hubertus Maximilian Mehdorn, Nicholas George Avgeropoulos, Andrea Salmaggi, Antonio Silvani, Samuel Aaron Goldlust et al. · 2017 · Journal of Neuro-Oncology
23. Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
    Mario E. Lacouture, Milan J. Anadkat, Matthew T. Ballo, FABIO MASSAITI IWAMOTO, Suriya A. Jeyapalan, Renato V. La Rocca, Margaret A. Schwartz, Jennifer N Serventi, Martin Glas · 2020 · Frontiers in Oncology
24. Electrotherapies for Glioblastoma
    Elise P. W. Jenkins, Alina Finch, Magda Gerigk, Iasonas F. Triantis, Colin Watts, George G. Malliaras · 2021 · Advanced Science
25. A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
    Pauline Latzer, Henning Zelba, Florian Battke, Annekathrin Reinhardt, Borong Shao, Oliver Bartsch, Armin Rabsteyn, Johannes Harter, Martin Schulze, Thomas Okech et al. · 2024 · Nature Communications
26. Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
    Brecht Decraene, Yihan Yang, Frederik De Smet, Abhishek Dinkarnath Garg, Patrizia Agostinis, Steven De Vleeschouwer · 2022 · Genes and Immunity
27. On glioblastoma and the search for a cure: where do we stand?
    John I. Bianco, Chiara Bastiancich, Aleksander Jankovski, Anne des Rieux, Véronique Préat A, Fabienne Danhier · 2017 · Cellular and Molecular Life Sciences
28. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database
    Ping Zhu, Xianglin L. Du, Jay‐Jiguang Zhu, Yoshua Esquenazi · 2019 · Journal of neurosurgery
29. Intracranial meningiomas: an update of the 2021 World Health Organization classifications and review of management with a focus on radiation therapy
    Varun Yarabarla, Amrutha Mylarapu, Tatiana Han, Susan Lynne McGovern, Shaan Mohammed Raza, Thomas Hendrix Beckham · 2023 · Frontiers in Oncology
30. An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma
    Kenneth D. Swanson, Edwin Lok, Eric T. Wong · 2016 · Current Neurology and Neuroscience Reports
31. Tumor treating fields for high-grade gliomas
    Chengke Luo, Shengchao Xu, Gan Dai, Zhi‐Qiang Xiao, Ling Chen, Zhixiong Liu · 2020 · Biomedicine & Pharmacotherapy
32. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies
    Sandeep Mittal, Neil V. Klinger, Sharon K. Michelhaugh, Geoffrey R. Barger, Susan C. Pannullo, Csaba Juhász · 2017 · Journal of neurosurgery
33. TTFields: where does all the skepticism come from?
    Wolfgang Wick · 2016 · Neuro-Oncology
34. NovoTTF™-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL™ system user study
    Aafia Chaudhry, Laura M. Benson, Michael Varshaver, Ori Farber, Uri Weinberg, Eilon David Kirson, Yoram Palti · 2015 · World Journal of Surgical Oncology
35. Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas
    Samantha Reiss, Prakirthi Yerram, Lisa R. Modelevsky, Christian Grommes · 2017 · Journal for ImmunoTherapy of Cancer
36. A Review of the Economic Burden of Glioblastoma and the Cost Effectiveness of Pharmacologic Treatments
    Andrew J. Messali, Reginald Villacorta, Joel W. Hay · 2014 · PharmacoEconomics
37. Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells
    Neuhaus, Eric, Zirjacks, Lisa, Ganser, Katrin, Klumpp, Lukas, Schüler, Uwe, Zips, Daniel, Eckert, Franziska, Huber, Stephan M. · 2019 · Cancers
38. Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
    Yaara Porat, Moshe Giladi, Rosa S. Schneiderman, Roni Blat, Anna Shteingauz, Einav Zeevi, Mijal Munster, Tali Voloshin, Noa Kaynan, Orna Tal et al. · 2017 · Journal of Visualized Experiments
39. Repurposing drugs for glioblastoma: From bench to bedside
    João Basso, Ana Miranda, João Sousa, Alberto A. C. C. Pais, Carla Vitorino · 2018 · Cancer Letters
40. Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations
    Anders Rosendal Korshoej, Frederik Lundgaard Hansen, Nikola Mikic, Gorm von Öettingen, Jens Christian Hedemann Sørensen, Axel Thielscher · 2018 · PLoS ONE
41. Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
    Yunhui Jo, Eun Ho Kim, Sei Sai, Jin Su Kim, Jae-Min Cho, Hyeongi Kim, Jeong‐Hwa Baek, Jeong‐Yub Kim, Sang‐Gu Hwang, Myonggeun Yoon · 2018 · International Journal of Molecular Sciences
42. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
    Shi, Wenyin, Blumenthal, Deborah T., Oberheim Bush, Nancy Ann, Kebir, Sied, Lukas, Rimas V., Muragaki, Yoshihiro, Zhu, Jay-Jiguang, Glas, Martin · 2020 · Journal of Neuro-Oncology
43. The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial
    Linda Dirven, Martin J. van den Bent, Andrew Bottomley, Nelly van der Meer, Bronno van der Holt, Maaike J. Vos, Annemiek Walenkamp, Laurens Victor Beerepoot, Monique C.J. Hanse, Jaap C. Reijneveld et al. · 2015 · European Journal of Cancer
44. Recurrent Malignant Gliomas
    John P. Kirkpatrick, John Howard Sampson · 2014 · Seminars in Radiation Oncology
45. Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research
    Upasana Sahu, Rolf F. Barth, Yoshihiro Otani, Ryan McCormack, Balveen Kaur · 2022 · Journal of Neuropathology & Experimental Neurology
46. Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
    Aleksei A. Stepanenko, Vladimir Pavlovich Chekhonin · 2018 · Cancers
47. Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study
    Guangrong Lu, Mayank Rao, Ping Zhu, Buqing Liang, Rasheda El‐Nazer, Ekokobe Fonkem, Meenakshi B. Bhattacharjee, Jay‐Jiguang Zhu · 2019 · Frontiers in Neurology
48. The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy
    Guilong Tanzhu, Liu Chen, Gang Xiao, Wen Shi, Haiqin Peng, Dikang Chen, Rongrong Zhou · 2022 · Cell Death Discovery
49. Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences
    Stefanie Quach, Michael Schmutzer-Sondergeld, Christoph Schwartz, Jonathan Weller, Sebastian Siller, Maximilian Aumiller, Christian Heckl, Robert Forbrig, Maximilian Niyazi, Rupert Egensperger et al. · 2021 · Cancers
50. The distinguishing electrical properties of cancer cells
    Elisabetta Di Gregorio, S.L. Israel, Michael Staelens, Gabriella Tankel, Karthik Shankar, Jack A. Tuszyński · 2022 · Physics of Life Reviews
51. Mechanical nanosurgery of chemoresistant glioblastoma using magnetically controlled carbon nanotubes
    Xian Wang, Zheyuan Gong, Tiancong Wang, Junhui Law, Xin Chen, Siyi Wanggou, Jintian Wang, Binbin Ying, Michelle A. Francisco, Weifan Dong et al. · 2023 · Science Advances
52. Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma
    Simon Khagi, Rupesh R Kotecha, Na Tosha Gatson, Suriya A. Jeyapalan, Huda Ismail Abdullah, Nicholas George Avgeropoulos, Eleni Batzianouli, Moshe Giladi, Leonardo Lustgarten, Samuel Aaron Goldlust · 2024 · The Oncologist
53. An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications
    Narasimha Kumar Karanam, Michael D. Story · 2020 · International Journal of Radiation Biology
54. Tumor Microenvironment in Glioma Invasion
    Sho Tamai, Toshiya Ichinose, Taishi Tsutsui, Shingo Tanaka, Farida Garaeva, Hemragul Sabit, Mitsutoshi Nakada · 2022 · Brain Sciences
55. Triboelectric‐Responsive Drug Delivery Hydrogel for Accelerating Infected Wound Healing
    Xuan Qin, Haoliang Shi, Zhen Wen, Binbin Chu, Hongyang Li, Houyu Wang, Yao He, Xuhui Sun · 2024 · Advanced Healthcare Materials
56. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma
    Jennifer Leigh Clarke, Elizabeth C. Neil, Robert Terziev, Philip H. Gutin, Igor J. Barani, Thomas Joseph Kaley, Andrew B. Lassman, Timothy An-thy Chan, Josh Yamada, Lisa Marie DeAngelis et al. · 2017 · International Journal of Radiation Oncology*Biology*Physics
57. Historical Perspective on Surgery and Survival with Glioblastoma: How Far Have We Come?
    Ian E. McCutcheon, Mark C. Preul · 2021 · World Neurosurgery
58. Progress and prospect in tumor treating fields treatment of glioblastoma
    Shiyu Liu, Weiyan Shi, Qin Zhao, Zhuangzhuang Zheng, Zijing Liu, Lingbin Meng, Lihua Dong, Xin Mei Jiang · 2021 · Biomedicine & Pharmacotherapy
59. The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review
    Linda Dirven, MARTIN J.B. TAPHOORN, Jaap C. Reijneveld, Jane M. Blazeby, Marc Jacobs, Andrea L. Pusic, Edoardo La Sala, Roger Stupp, Peter M. Fayers, Fabio Efficace · 2014 · European Journal of Cancer
60. Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study
    Anders Rosendal Korshoej, Guilherme B. Saturnino, Line Kirkegaard Rasmussen, Gorm von Öettingen, Jens Christian Hedemann Sørensen, Axel Thielscher · 2016 · PLoS ONE
61. Emerging targeted therapies for glioma
    Julie J. Miller, Patrick Yung Wen · 2016 · Expert Opinion on Emerging Drugs
62. Response assessment of NovoTTF‐100A versus best physician's choice chemotherapy in recurrent glioblastoma
    Eric T. Wong, Edwin Lok, Kenneth D. Swanson, Shiva Gautam, Herbert H. Engelhard, Frank Scott Lieberman, Sophie Taillibert, Zvi Ram, John Lee Villano · 2014 · Cancer Medicine
63. Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series
    Marc Charles Chamberlain, Bryan T. Kim · 2017 · Journal of Neuro-Oncology
64. Tumor treating fields: a new approach to glioblastoma therapy
    Jonathan W. Rick, Ankush Chandra, Manish Kumar Aghi · 2018 · Journal of Neuro-Oncology
65. Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study
    Hao Wu, Lin Yang, Hanjie Liu, Dan Zhou, Dikang Chen, Xiaoque Zheng, Hui Yang, Chong Li, Jiusheng Chang, Anhua Wu et al. · 2021 · CNS Neuroscience & Therapeutics
66. Electromagnetic field investigation on different cancer cell lines
    Nenad Filipović, Tijana R. Djukic, Milos D. Radovic, Danijela M. Cvetković, Milena G. Milutinović, Snežana Marković, Aleksandar S. Peulić, Branislav M. Jeremic · 2014 · Cancer Cell International
67. Response Patterns of Recurrent Glioblastomas Treated With Tumor-Treating Fields
    Josef Vymazal, Eric T. Wong · 2014 · Seminars in Oncology
68. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery
    Mayur Sharma, Jason L. Schroeder, Paul J. Elson, Antonio Meola, Gene H. Barnett, Michael A. Vogelbaum, John H. Suh, Samuel T. Chao, Alireza Mohammad Mohammadi, Glen H. J. Stevens et al. · 2018 · Journal of neurosurgery
69. Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment
    Francesca A. Carrieri, Caleb Smack, Ismaeel Siddiqui, Lawrence Richard Kleinberg, Phuoc Tho Tran · 2020 · Frontiers in Oncology
70. Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models
    Yelena Mumblat, Antonia Martinez-Conde, Ori Braten, Mijal Munster, Eyal Dor-On, Rosa S. Schneiderman, Yaara Porat, Tali Voloshin, Shiri Davidi, Roni Blatt et al. · 2021 · Lung Cancer
71. Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival
    Benjamin M. Ellingson, Patrick Yung Wen, Susan Marina Chang, Martin J. van den Bent, Michael A. Vogelbaum, Gang Li, Shanpeng J. Li, Jiyoon Kim, Gilbert Youssef, Wolfgang Wick et al. · 2023 · Neuro-Oncology
72. Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives
    Ilaria Salvato, Antonio Marchini · 2024 · Cancers
73. Management of glioblastoma in elderly patients
    Jacob S. Young, Steven J. Chmura, Derek Alan Wainwright, Bakhtiar Yamini, Katherine B. Peters, Rimas Vincas Lukas · 2017 · Journal of the Neurological Sciences
74. Management of Glioblastoma, Present and Future
    Nancy Ann Oberheim Bush, Shawn L. Hervey‐Jumper, Mitchel Stuart Berger · 2019 · World Neurosurgery
75. Health-related Quality of Life in Patients with Brain Tumors: Limitations and Additional Outcome Measures
    Linda Dirven, Jaap C. Reijneveld, Neil K. Aaronson, Andrew Bottomley, Bernard M.J. Uitdehaag, MARTIN J.B. TAPHOORN · 2013 · Current Neurology and Neuroscience Reports
76. Survival and complications of stereotactic radiosurgery
    Kaleigh Fetcko, Rimas Vincas Lukas, Gordon A. Watson, Lingjiao Zhang, Mahua Dey · 2017 · Medicine
77. Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma
    Melinda Nay Tea, Santosh Isaac Poonnoose, Stuart Maxwell Pitson · 2020 · Cancers
78. Current usage of tumor treating fields for glioblastoma
    Andrew B. Lassman, Adela Joanta-Gomez, Peter Pan, Wolfgang Wick · 2020 · Neuro-Oncology Advances
79. Advances in the treatment of newly diagnosed glioblastoma
    Brett James Theeler, Mark R. Gilbert · 2015 · BMC Medicine
80. A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma
    John E. Trusheim, Erin M Dunbar, James D. Battiste, FABIO MASSAITI IWAMOTO, Nimish A. Mohile, Denise Damek, Daniela Annenelie Bota, Jennifer Connelly · 2016 · CNS Oncology
81. Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma
    Edwin Lok, Pyay San, Van Hua, Melissa Phung, Eric T. Wong · 2017 · Cancer Medicine
82. Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
    Wenlin Chen, Yuekun Wang, Binghao Zhao, Penghao Liu, Lei Liu, Yu Wang, Wenbin Ma · 2021 · Frontiers in Oncology
83. Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy
    Ahmet Kaynak, Harold W. Davis, Andrei B. Kogan, J. H. Lee, Daria A. Narmoneva, Xiaoyang Qi · 2022 · Cancers
84. Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood–Brain Barrier In Vitro and In Vivo
    Ellaine Salvador, Almuth Friederike Kessler, Dominik Domröse, Julia Hörmann, Clara M. Schaeffer, Aiste Giniunaite, Małgorzata Burek, Catherine Tempel-Brami, Tali Voloshin, Alexandra Volodin et al. · 2022 · Biomolecules
85. Current status of intratumoral therapy for glioblastoma
    Ankit Indravadan Mehta, Andreas A. Linninger, Maciej S. Lesniak, Herbert H. Engelhard · 2015 · Journal of Neuro-Oncology
86. Bevacizumab for glioblastoma
    Yoshitaka Narita · 2015 · Therapeutics and Clinical Risk Management
87. Electrical stimulation towards melanoma therapy via liquid metal printed electronics on skin
    Jun Li, Cangran Guo, Zhongshuai Wang, Kai Gao, Xudong Shi, Jing Liu · 2016 · Clinical and Translational Medicine
88. The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells
    Paul A. Clark, Jordan T. Gaal, Joslyn K. Strebe, Cheri A. Pasch, Dustin A. Deming, John S. Kuo, H. Ian Robins · 2016 · Journal of Clinical Neuroscience
89. Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma
    Nuno Cruz, Manuel Herculano-Carvalho, Diogo Roque, Cláudia C. Faria, Rita Cascão, Hugo Alexandre Ferreira, Catarina Pinto Reis, Nuno Matela · 2023 · Pharmaceutics
90. Recalcitrant Issues and New Frontiers in Nano-Pharmacology
    Vinay Bhardwaj, Ajeet Kumar Kaushik, Ziad A. Khatib, Madhavan G. Nair, Anthony J. McGoron · 2019 · Frontiers in Pharmacology
91. Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
    Hao Wu, Jialin Liu, Zhifei Wang, Wen Yuan, Ling Chen · 2021 · CNS Neuroscience & Therapeutics
92. New Approaches to Glioblastoma
    Mustafa Khasraw, Yoko Fujita, Catalina Lee-Chang, Irina V. Balyasnikova, Hinda Najem, Amy B. Heimberger · 2021 · Annual Review of Medicine
93. High-Grade Glioma Management and Response Assessment—Recent Advances and Current Challenges
    Maria Khan, Ankur Markand Sharma, Marshall W. Pitz, Shaun K. Loewen, Harvey Charles Quon, Anne-Marie Poulin, Marco Essig · 2016 · Current Oncology
94. Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients
    Eudocia Q. Lee, Michael Weller, Joohee Sul, Stephen Joseph Bagley, Solmaz Sahebjam, Martin J. van den Bent, Manmeet Singh Ahluwalia, Jian Li Campian, Evanthia Galanis, Mark R. Gilbert et al. · 2020 · Neuro-Oncology
95. Barium Titanate Nanoparticles Sensitise Treatment-Resistant Breast Cancer Cells to the Antitumor Action of Tumour-Treating Fields
    Yi Na Yoon, Dae-Sik Lee, Hyung Ju Park, Jae‐Sung Kim · 2020 · Scientific Reports
96. Ion Channels as Therapeutic Targets in High Grade Gliomas
    Michaela Griffin, Raheela N. Khan, Surajit Basu, Stuart James Smith · 2020 · Cancers
97. Modeling Tumor Treating Fields (TTFields) application in single cells during metaphase and telophase
    Wenger, Cornelia, Giladi, Moshe, Bomzon, Ze'ev, Salvador, Ricardo, Basser, Peter J., Miranda, Pedro C. · 2015 · 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
98. Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma
    Nusrat Jahan, Hammad Talat, Andrea Alonso, Dipongkor Saha, William T. Curry · 2019 · OncoImmunology
99. A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights
    Xing Li, Kaida Liu, Lidong Xing, Boris Rubinsky · 2023 · Radiology and Oncology
100. Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms
     Christopher Chang, Velina S. Chavarro, Jakob V. E. Gerstl, Sarah E. Blitz, Lennard Spanehl, Daniel Dubinski, Pablo Andres Valdes, L. Tran, Saksham Gupta, Luisa Esposito et al. · 2024 · International Journal of Molecular Sciences